Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nabarun Dasgupta

‘Unprecedented’ decline in US drug overdose deaths gives experts hope

A new report states fatalities had decreased by 10% as of April 2024 while 911 first-responder calls were 16.7% lower

The Guardian - US

Recent Overdose Trends Underline the Folly of the War on Drugs

Both Donald Trump and Kamala Harris support supply-side tactics that are worse than ineffective.

Drug Deaths Are Finally Declining. Nobody Really Knows Why.

One thing seems clear: Drug warriors do not deserve credit for the turnaround, although they deserve blame for the previous explosion in fatal overdoses.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

US opioid crisis: Hope for new approach as naloxone machines spread in 2023

Vending machines with free overdose-reversal drugs are being embraced across US, but misconceptions remain a hurdle.

The latest college campus freebies? Naloxone and fentanyl test strips

The teen fentanyl crisis is following students onto college campuses. Here's what students and staff are doing about it.

A deadly new street drug caught the U.S. off guard. Experts say it'll happen again

A dangerous chemical called xylazine is being mixed into fentanyl across the U.S., but who's doing it and why is a mystery. The government still doesn't identify and track new drug threats.

Why over-the-counter Narcan may not reach those most in need

If insurers or governments don't step up, addiction experts fear it could widen health disparities and undercut the FDA's goals of addressing a "dire public health need."

inkl

Read news from The Economist, FT, and more,
with one subscription

States, cities scramble to combat animal ‘tranq’ in street drugs

As a dangerous new additive found in fentanyl and other street drugs surges from coast to coast, health officials in nearly every state are scrambling to track it.

Tribune News Service

A major drugmaker plans to sell overdose-reversal nasal spray Narcan over the counter

A major drugmaker plans to sell overdose-reversal nasal spray Narcan over the counter

Emergent BioSolutions has applied to the Food and Drug Administration to sell the opioid overdose-reversal drug over the counter. Addiction experts say it may be a key step to lower fentanyl deaths.

Is 'rainbow fentanyl' a threat to your kids this Halloween? Experts say no

Is 'rainbow fentanyl' a threat to your kids this Halloween? Experts say no

The Drug Enforcement Administration is warning that drug dealers are marketing rainbow-colored fentanyl to kids. Many drug experts say that's likely not happening.

"Tranq dope" spreads to more cities

"Tranq dope" spreads to more cities

Xylazine is contaminating the drug supply, causing grisly injuries and death

Fear-mongering about fentanyl for kids

Fear-mongering about fentanyl for kids

One expert characterized the DEA's claims as propaganda that was "divorced from reality"

1

People

Keechant Sewell

Nabarun Dasgupta

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Food and Drug Administration

Ohio State University

University of North Carolina

Drug Enforcement Administration

Emergent BioSolutions

the University of North Carolina at Chapel Hill

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

235,484 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play